Abstract:Objective To assess the risk of atrial fibrillation (AF) recurrence at 12-36 months after high-power short-duration (HPSD) radiofrequency ablation post-procedure in elderly patients with AF and to investigate its safety and predictors for recurrence. Methods A retrospective analysis was conducted of the clinical data of 139 elderly AF patients who underwent catheter ablation at the 983rd Hospital of the Joint Logistics Support Force from January 2020 to December 2022. According to the ablation strategy, they were divided into HPSD group (n=72) and low-power long-duration (LPLD) group (n=67). Baseline data, preoperative echocardiographic parameters, and procedural data were collected. The patients were followed up for 12-36 months postoperatively. SPSS 21.0 was used for statistical analysis. Data comparison between two groups was performed using t test, Mann-Whitney U test orχ2 test depending on data type. Logistic regression was used to identify independent risk factors for postoperative AF recurrence. Kaplan-Meier analysis was employed to assess the long-term AF-free survival rates in the HPSD and LPLD groups. Results The HPSD group showed significantly shorter ablation times for bilateral pulmonary veins isolation than the LPLD group [right:(14.97±3.70) vs (18.00±3.56) min; left:(13.54±5.59) vs (16.30±4.37) min; both P<0.05]. Logistic regression analysis identified persistent AF (OR=5.50,95%CI 1.994-15.171), heart failure (OR=7.92,95%CI 2.484-25.257), left atrial diameter (OR=1.111,95%CI 1.028-1.202), and left ventricular diameter (OR=1.105 per mm, 95%CI 1.030-1.186) as independent risk factors for recurrence (all P<0.05). No statistically significant difference in cumulative recurrence rates was observed between the HPSD and LPLD groups at 12-36 months [ 33.3% (24/72) vs 37.3% (25/67), P=0.634]. Conclusion HPSD ablation improves procedural efficiency without increasing mid-to-long-term recurrence risk. Persistent AF, heart failure, and cardiac structural remodeling (left atrial/ventricular enlargement) are key predictors of recurrence in elderly AF patients.